Filter information in our deals and cases database
On 9 April 2020, a flight with the first cargo delivering one million surgical face masks arrived in Latvia. A total of 2 million surgical masks will be delivered to Latvia.
MoreTGS Baltic's team, led by partner Leonid Tolstov, advised the leading Estonian biotechnology company TBD-Biodiscovery and its sole shareholder on involving a Dutch investor from SEAL Investments B.V., who acquired 30% of the company's shares and will be investing a total of EUR 4.5 million in the company in the next few years. This is one of the largest foreign investments in an Estonian biotechnology company.
MoreTGS Baltic is a key legal advisor for Lithuanian subsidiary of GlaxoSmithKline, a science-led global healthcare company. We advised Client on a Pan-Baltic level in a project related to development of internal public procurement policies, ebracing the best practices for various corporate and public procurement issues, including but not limited to protection of confidencial information, fair competition and proper participation in tender produres and etc. These policies reflected boath national regulation and case law, as well as the case law of the European Court of Justice and provisions of the EU public procurement directives.
TGS Baltic advised VIKONDA Group (VIKONDA Concern), one of the biggest business groups in Lithuania with significant interests in food, trade, crop, media industries, construction, and other services, with a consolidated annual turnover of approximately EUR 145 million, on a complex holding restructuring.
More
Andra Rubene, Attorney at Law, Partner, and Rūdolfs Vilsons, Associate at TGS Baltic assisted BENU Aptieka Latvija SIA, one of the leading retail of medicines chains in the Baltics, with acquisition of 100% shares SIA Cēsu Vecpilsētas Aptieka, a pharmacy in Cēsis, Latvia from a number of private persons, thereby expanding Benu network of more than 66 pharmacies in Latvia.
MoreOn 1 June 2017, at a special awards ceremony at the Intercontinental Hotel in Warsaw, Eugenija Sutkienė was named the Market Maker for Lithuania, which is a special lifetime achievement award given to a senior lawyer identified by peers as having played the most influential and significant role in creating the country’s modern legal market
MoreThe firm’s M&A team led by associate partner Sander Kärson advised the strategic investor Viru Haigla on the acquisition of Karell Kiirabi from U.S. Invest.
MoreTGS Baltic successfully represented an orthopaedic technical products manufacturer in Lithuania in a dispute with the National Health Insurance Fund with regard to the right to issue orthopaedic technical products to the patients and receive compensation from state funds.
MoreTGS Baltic successfully represented one of the largest companies in the sector of orthopaedic technical products in a legal dispute against the Republic of Lithuania regarding the refusal to compensate the client for orthopaedic technical products issued by the company to patients (case re State liability).
MoreIFLR1000 (International Financial Law Review) is the guide of world’s leading financial law firms. The guide analysis and ranks more than 120 jurisdictions in the world.
MoreTGS Baltic is the main legal advisor of Northway Group, which consists of 11 companies dealing in pharmacy and biotechnologies, provision of health care services and investments.
MoreTGS Baltic advised Novo Nordisk on the reorganization of its supply chain for medicinal products in the Baltic States, and prepared the relevant documentation.
MoreTGS Baltic provides day-to-day legal assistance to a manufacturer and distributor of medicinal products in Latvia, including regarding discounts for medicinal products offered to hospitals through public tenders and donations of medicinal products to hospitals, clinical trials, safety reporting, suspected unexpected serious adverse reactions, scientific services, M&A and corporate, employment, data protection, bribery and competition law issues.
TGS Baltic drafted an agreement of manufacturers of medicinal products with the National Health Service on including of innovative medicinal products in the list of reimbursable medicinal products pursuant to the requirements set by the Cabinet regulations No.899 “Procedures for the Reimbursement of Expenditures for the Acquisition of Medicinal Products and Medicinal Devices Intended for Out-patient Medical Treatment”.
TGS Baltic advised Valeant Pharmaceuticals International, Inc. on all legal matters related to the collaterals and securities in Lithuania that were created as per financing from Goldman Sachs Bank USA for the acquisition of Bausch & Lomb Holdings Incorporated. Valeant Pharmaceuticals owns and operates a significant production facility in Lithuania.
Chambers Europe, a major European legal directory, gave TGS Baltic the highest rankings in corporate/commercial, employment, competition/antitrust and energy practices in its 2013 edition.
MoreLaw firm TGS Baltic and its lawyers are ranked in top tiers in Chambers Global’s newest, 2013 edition. The edition analyzes corporate/commercial and dispute resolution practice areas in the Baltics.
MoreTGS Baltic represented a number of associations of healthcare institutions in the successful request for the European Commission to open a case regarding potential violations of EU law in proposed amendments to Lithuania's Law on Health Insurance.
TGS Baltic counselled Tamro, the largest pharmaceutical distributor in the Baltics, on tax issues related to best jurisdiction for establishing a holding in the Baltic States.
MoreTGS Baltic provided tax advisory services to Northway Medical Centres, one of the largest private medical centres in Lithuania providing comprehensive medical, day surgery and rehabilitation services, regarding invoicing, VAT, income tax and other tax law issues.